![Laboratory with lab coats in the back](/media/6664/stvg_2_2022_lab_22_hess.jpg?anchor=center&mode=crop&quality=90&width=1320&height=660&rnd=133128375780000000)
We currently employ approximately 1,450 full time employees across the country, providing a salary injection of $157 million into the Canadian economy. We have two divisional headquarters in Mississauga, Ontario and Montréal, Quebec, and an administrative office in Quebec City.
![Édifice de GSK](/media/6912/image001.png?center=0.44920993227990968,0.50666666666666671&mode=crop&quality=90&width=624&height=416&rnd=133136512390000000)
100 Milverton Drive
Suite 800
Mississauga, Ontario
L5R 4H1
Canada
Tel: 905-819-3000
![Édifice du Bureau d’affaires du Québec](/media/6911/image002.png?anchor=center&mode=crop&quality=90&width=624&height=416&rnd=133136513080000000)
75, rue Queen, suite 1400
Montréal, Québec
H3C 2N6
Canada
Tel: 1-833-737-1277
![Édifice du Centre de production](/media/6910/gsk-canada_stefoy_productionfacility.jpg?anchor=center&mode=crop&quality=90&width=624&height=416&rnd=133136513430000000)
2323, boul. Du Parc technologique
Québec
G1P 4R8
Canada
Tel: 418-650-0010
![Édifice des bureaux administratifs](/media/6909/18809_gsk_twitter_october_oct-xx_en-fr_v1.jpg?anchor=center&mode=crop&quality=90&width=624&height=416&rnd=133136512680000000)
2324 du parc technologique Blvd.
Ste-Foy, Québec
G1P 4R8
Canada
Tel: 418-650-0010
Manufacturing
The Ste-Foy vaccine manufacturing site currently produces an important share of Canada’s seasonal influenza vaccine and responsible for the domestic supply of the country’s pandemic influenza vaccine requirements.
Research & development
We have invested more than $2 billion since 2001 in Canadian pharmaceutical and vaccines Research & Development (R&D), with over 109 million in 2022 alone. In 2022, we invested over $21 million into 54 active clinical trials across Canada involving 3,700 active subjects.
![Man looking at a monitor](/media/6667/innovation-landing-header-scientist-at-computer-01.jpg?center=0.3325,0.34333333333333332&mode=crop&quality=90&width=800&height=500&rnd=133128375760000000)
We are committed to working in partnership with charities and community based organizations who reflect our key values, supporting programs with a local, national or international reach.
Environmental sustainability
In October 2018, we launched a Centralized Waste program involving the removal of individual waste containers from offices to promote environmental consciousness and reduce our contribution to landfills.
In November 2020, as a global biopharmaceutical company we announced ambitious new environmental sustainability goals in both climate and nature, aiming to have a net zero impact on climate and a net positive impact on nature by 2030, across our entire value chain – from lab to patient. We’ve set clear and measurable targets to help achieve these goals.
![Two wind turbines at our R&D site, Ware, UK](/media/1136/wind-turbine-green.jpg?anchor=center&mode=crop&quality=90&width=800&height=500&rnd=131421004180000000)
![Man in laboratory setting inspecting a blue vial](/media/6795/gsk_rix_24_10_18_p_d2_s1_128_re-sized.jpg?anchor=center&mode=crop&quality=90&width=624&height=416&rnd=133128375770000000)
Global GSK at a glance
Learn more about some of our key achievements in pursuing our purpose to get ahead of disease.